Global Pharmaceutical CMO and CDMO Market Research Report 2023

Global Pharmaceutical CMO and CDMO Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical CMO and CDMO Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 API CMO and CDMO
1.2.3 FDF CMO and CDMO
1.2.4 Packaging CMO
1.2.5 Clinical CDMO
1.3 Market by Application
1.3.1 Global Pharmaceutical CMO and CDMO Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical CMO and CDMO Market Perspective (2018-2029)
2.2 Pharmaceutical CMO and CDMO Growth Trends by Region
2.2.1 Global Pharmaceutical CMO and CDMO Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Pharmaceutical CMO and CDMO Historic Market Size by Region (2018-2023)
2.2.3 Pharmaceutical CMO and CDMO Forecasted Market Size by Region (2024-2029)
2.3 Pharmaceutical CMO and CDMO Market Dynamics
2.3.1 Pharmaceutical CMO and CDMO Industry Trends
2.3.2 Pharmaceutical CMO and CDMO Market Drivers
2.3.3 Pharmaceutical CMO and CDMO Market Challenges
2.3.4 Pharmaceutical CMO and CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical CMO and CDMO Players by Revenue
3.1.1 Global Top Pharmaceutical CMO and CDMO Players by Revenue (2018-2023)
3.1.2 Global Pharmaceutical CMO and CDMO Revenue Market Share by Players (2018-2023)
3.2 Global Pharmaceutical CMO and CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Pharmaceutical CMO and CDMO Revenue
3.4 Global Pharmaceutical CMO and CDMO Market Concentration Ratio
3.4.1 Global Pharmaceutical CMO and CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical CMO and CDMO Revenue in 2022
3.5 Pharmaceutical CMO and CDMO Key Players Head office and Area Served
3.6 Key Players Pharmaceutical CMO and CDMO Product Solution and Service
3.7 Date of Enter into Pharmaceutical CMO and CDMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical CMO and CDMO Breakdown Data by Type
4.1 Global Pharmaceutical CMO and CDMO Historic Market Size by Type (2018-2023)
4.2 Global Pharmaceutical CMO and CDMO Forecasted Market Size by Type (2024-2029)
5 Pharmaceutical CMO and CDMO Breakdown Data by Application
5.1 Global Pharmaceutical CMO and CDMO Historic Market Size by Application (2018-2023)
5.2 Global Pharmaceutical CMO and CDMO Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Pharmaceutical CMO and CDMO Market Size (2018-2029)
6.2 North America Pharmaceutical CMO and CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Pharmaceutical CMO and CDMO Market Size by Country (2018-2023)
6.4 North America Pharmaceutical CMO and CDMO Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical CMO and CDMO Market Size (2018-2029)
7.2 Europe Pharmaceutical CMO and CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Pharmaceutical CMO and CDMO Market Size by Country (2018-2023)
7.4 Europe Pharmaceutical CMO and CDMO Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical CMO and CDMO Market Size (2018-2029)
8.2 Asia-Pacific Pharmaceutical CMO and CDMO Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Pharmaceutical CMO and CDMO Market Size by Region (2018-2023)
8.4 Asia-Pacific Pharmaceutical CMO and CDMO Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical CMO and CDMO Market Size (2018-2029)
9.2 Latin America Pharmaceutical CMO and CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Pharmaceutical CMO and CDMO Market Size by Country (2018-2023)
9.4 Latin America Pharmaceutical CMO and CDMO Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical CMO and CDMO Market Size (2018-2029)
10.2 Middle East & Africa Pharmaceutical CMO and CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Pharmaceutical CMO and CDMO Market Size by Country (2018-2023)
10.4 Middle East & Africa Pharmaceutical CMO and CDMO Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Detail
11.1.2 Lonza Business Overview
11.1.3 Lonza Pharmaceutical CMO and CDMO Introduction
11.1.4 Lonza Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.1.5 Lonza Recent Development
11.2 Catalent
11.2.1 Catalent Company Detail
11.2.2 Catalent Business Overview
11.2.3 Catalent Pharmaceutical CMO and CDMO Introduction
11.2.4 Catalent Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.2.5 Catalent Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Pharmaceutical CMO and CDMO Introduction
11.3.4 Thermo Fisher Scientific Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 Samsung Biologics
11.4.1 Samsung Biologics Company Detail
11.4.2 Samsung Biologics Business Overview
11.4.3 Samsung Biologics Pharmaceutical CMO and CDMO Introduction
11.4.4 Samsung Biologics Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.4.5 Samsung Biologics Recent Development
11.5 Fareva
11.5.1 Fareva Company Detail
11.5.2 Fareva Business Overview
11.5.3 Fareva Pharmaceutical CMO and CDMO Introduction
11.5.4 Fareva Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.5.5 Fareva Recent Development
11.6 WuXi AppTech
11.6.1 WuXi AppTech Company Detail
11.6.2 WuXi AppTech Business Overview
11.6.3 WuXi AppTech Pharmaceutical CMO and CDMO Introduction
11.6.4 WuXi AppTech Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.6.5 WuXi AppTech Recent Development
11.7 WuXi Biologics
11.7.1 WuXi Biologics Company Detail
11.7.2 WuXi Biologics Business Overview
11.7.3 WuXi Biologics Pharmaceutical CMO and CDMO Introduction
11.7.4 WuXi Biologics Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.7.5 WuXi Biologics Recent Development
11.8 Siegfried
11.8.1 Siegfried Company Detail
11.8.2 Siegfried Business Overview
11.8.3 Siegfried Pharmaceutical CMO and CDMO Introduction
11.8.4 Siegfried Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.8.5 Siegfried Recent Development
11.9 FUJIFILM Diosynth Biotechnologies
11.9.1 FUJIFILM Diosynth Biotechnologies Company Detail
11.9.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.9.3 FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO and CDMO Introduction
11.9.4 FUJIFILM Diosynth Biotechnologies Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.9.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.10 Asymchem
11.10.1 Asymchem Company Detail
11.10.2 Asymchem Business Overview
11.10.3 Asymchem Pharmaceutical CMO and CDMO Introduction
11.10.4 Asymchem Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.10.5 Asymchem Recent Development
11.11 Pfizer CentreOne
11.11.1 Pfizer CentreOne Company Detail
11.11.2 Pfizer CentreOne Business Overview
11.11.3 Pfizer CentreOne Pharmaceutical CMO and CDMO Introduction
11.11.4 Pfizer CentreOne Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.11.5 Pfizer CentreOne Recent Development
11.12 Delpharm
11.12.1 Delpharm Company Detail
11.12.2 Delpharm Business Overview
11.12.3 Delpharm Pharmaceutical CMO and CDMO Introduction
11.12.4 Delpharm Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.12.5 Delpharm Recent Development
11.13 Recipharm
11.13.1 Recipharm Company Detail
11.13.2 Recipharm Business Overview
11.13.3 Recipharm Pharmaceutical CMO and CDMO Introduction
11.13.4 Recipharm Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.13.5 Recipharm Recent Development
11.14 AGC Pharma Chemicals
11.14.1 AGC Pharma Chemicals Company Detail
11.14.2 AGC Pharma Chemicals Business Overview
11.14.3 AGC Pharma Chemicals Pharmaceutical CMO and CDMO Introduction
11.14.4 AGC Pharma Chemicals Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.14.5 AGC Pharma Chemicals Recent Development
11.15 Boehringer Ingelheim
11.15.1 Boehringer Ingelheim Company Detail
11.15.2 Boehringer Ingelheim Business Overview
11.15.3 Boehringer Ingelheim Pharmaceutical CMO and CDMO Introduction
11.15.4 Boehringer Ingelheim Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.15.5 Boehringer Ingelheim Recent Development
11.16 Vetter
11.16.1 Vetter Company Detail
11.16.2 Vetter Business Overview
11.16.3 Vetter Pharmaceutical CMO and CDMO Introduction
11.16.4 Vetter Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.16.5 Vetter Recent Development
11.17 Curia
11.17.1 Curia Company Detail
11.17.2 Curia Business Overview
11.17.3 Curia Pharmaceutical CMO and CDMO Introduction
11.17.4 Curia Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.17.5 Curia Recent Development
11.18 Aenova
11.18.1 Aenova Company Detail
11.18.2 Aenova Business Overview
11.18.3 Aenova Pharmaceutical CMO and CDMO Introduction
11.18.4 Aenova Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.18.5 Aenova Recent Development
11.19 Porton
11.19.1 Porton Company Detail
11.19.2 Porton Business Overview
11.19.3 Porton Pharmaceutical CMO and CDMO Introduction
11.19.4 Porton Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.19.5 Porton Recent Development
11.20 Piramal
11.20.1 Piramal Company Detail
11.20.2 Piramal Business Overview
11.20.3 Piramal Pharmaceutical CMO and CDMO Introduction
11.20.4 Piramal Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.20.5 Piramal Recent Development
11.21 Strides Pharma
11.21.1 Strides Pharma Company Detail
11.21.2 Strides Pharma Business Overview
11.21.3 Strides Pharma Pharmaceutical CMO and CDMO Introduction
11.21.4 Strides Pharma Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.21.5 Strides Pharma Recent Development
11.22 NextPharma
11.22.1 NextPharma Company Detail
11.22.2 NextPharma Business Overview
11.22.3 NextPharma Pharmaceutical CMO and CDMO Introduction
11.22.4 NextPharma Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.22.5 NextPharma Recent Development
11.23 Famar
11.23.1 Famar Company Detail
11.23.2 Famar Business Overview
11.23.3 Famar Pharmaceutical CMO and CDMO Introduction
11.23.4 Famar Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.23.5 Famar Recent Development
11.24 Jubilant
11.24.1 Jubilant Company Detail
11.24.2 Jubilant Business Overview
11.24.3 Jubilant Pharmaceutical CMO and CDMO Introduction
11.24.4 Jubilant Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.24.5 Jubilant Recent Development
11.25 Alcami
11.25.1 Alcami Company Detail
11.25.2 Alcami Business Overview
11.25.3 Alcami Pharmaceutical CMO and CDMO Introduction
11.25.4 Alcami Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.25.5 Alcami Recent Development
11.26 Euroapi
11.26.1 Euroapi Company Detail
11.26.2 Euroapi Business Overview
11.26.3 Euroapi Pharmaceutical CMO and CDMO Introduction
11.26.4 Euroapi Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.26.5 Euroapi Recent Development
11.27 Eurofins
11.27.1 Eurofins Company Detail
11.27.2 Eurofins Business Overview
11.27.3 Eurofins Pharmaceutical CMO and CDMO Introduction
11.27.4 Eurofins Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.27.5 Eurofins Recent Development
11.28 Avid Bioservices
11.28.1 Avid Bioservices Company Detail
11.28.2 Avid Bioservices Business Overview
11.28.3 Avid Bioservices Pharmaceutical CMO and CDMO Introduction
11.28.4 Avid Bioservices Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.28.5 Avid Bioservices Recent Development
11.29 BioVectra
11.29.1 BioVectra Company Detail
11.29.2 BioVectra Business Overview
11.29.3 BioVectra Pharmaceutical CMO and CDMO Introduction
11.29.4 BioVectra Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.29.5 BioVectra Recent Development
11.30 CPL
11.30.1 CPL Company Detail
11.30.2 CPL Business Overview
11.30.3 CPL Pharmaceutical CMO and CDMO Introduction
11.30.4 CPL Revenue in Pharmaceutical CMO and CDMO Business (2018-2023)
11.30.5 CPL Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Pharmaceutical CMO and CDMO Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of API CMO and CDMO
Table 3. Key Players of FDF CMO and CDMO
Table 4. Key Players of Packaging CMO
Table 5. Key Players of Clinical CDMO
Table 6. Global Pharmaceutical CMO and CDMO Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global Pharmaceutical CMO and CDMO Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Pharmaceutical CMO and CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Pharmaceutical CMO and CDMO Market Share by Region (2018-2023)
Table 10. Global Pharmaceutical CMO and CDMO Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Pharmaceutical CMO and CDMO Market Share by Region (2024-2029)
Table 12. Pharmaceutical CMO and CDMO Market Trends
Table 13. Pharmaceutical CMO and CDMO Market Drivers
Table 14. Pharmaceutical CMO and CDMO Market Challenges
Table 15. Pharmaceutical CMO and CDMO Market Restraints
Table 16. Global Pharmaceutical CMO and CDMO Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Pharmaceutical CMO and CDMO Market Share by Players (2018-2023)
Table 18. Global Top Pharmaceutical CMO and CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CMO and CDMO as of 2022)
Table 19. Ranking of Global Top Pharmaceutical CMO and CDMO Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Pharmaceutical CMO and CDMO Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Pharmaceutical CMO and CDMO Product Solution and Service
Table 23. Date of Enter into Pharmaceutical CMO and CDMO Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pharmaceutical CMO and CDMO Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Pharmaceutical CMO and CDMO Revenue Market Share by Type (2018-2023)
Table 27. Global Pharmaceutical CMO and CDMO Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Pharmaceutical CMO and CDMO Revenue Market Share by Type (2024-2029)
Table 29. Global Pharmaceutical CMO and CDMO Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Pharmaceutical CMO and CDMO Revenue Market Share by Application (2018-2023)
Table 31. Global Pharmaceutical CMO and CDMO Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Pharmaceutical CMO and CDMO Revenue Market Share by Application (2024-2029)
Table 33. North America Pharmaceutical CMO and CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 34. North America Pharmaceutical CMO and CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Pharmaceutical CMO and CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 36. Europe Pharmaceutical CMO and CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 37. Europe Pharmaceutical CMO and CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Pharmaceutical CMO and CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 39. Asia-Pacific Pharmaceutical CMO and CDMO Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 40. Asia-Pacific Pharmaceutical CMO and CDMO Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Pharmaceutical CMO and CDMO Market Size by Region (2024-2029) & (US$ Million)
Table 42. Latin America Pharmaceutical CMO and CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Latin America Pharmaceutical CMO and CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Pharmaceutical CMO and CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Pharmaceutical CMO and CDMO Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 46. Middle East & Africa Pharmaceutical CMO and CDMO Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Pharmaceutical CMO and CDMO Market Size by Country (2024-2029) & (US$ Million)
Table 48. Lonza Company Detail
Table 49. Lonza Business Overview
Table 50. Lonza Pharmaceutical CMO and CDMO Product
Table 51. Lonza Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 52. Lonza Recent Development
Table 53. Catalent Company Detail
Table 54. Catalent Business Overview
Table 55. Catalent Pharmaceutical CMO and CDMO Product
Table 56. Catalent Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 57. Catalent Recent Development
Table 58. Thermo Fisher Scientific Company Detail
Table 59. Thermo Fisher Scientific Business Overview
Table 60. Thermo Fisher Scientific Pharmaceutical CMO and CDMO Product
Table 61. Thermo Fisher Scientific Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 62. Thermo Fisher Scientific Recent Development
Table 63. Samsung Biologics Company Detail
Table 64. Samsung Biologics Business Overview
Table 65. Samsung Biologics Pharmaceutical CMO and CDMO Product
Table 66. Samsung Biologics Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 67. Samsung Biologics Recent Development
Table 68. Fareva Company Detail
Table 69. Fareva Business Overview
Table 70. Fareva Pharmaceutical CMO and CDMO Product
Table 71. Fareva Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 72. Fareva Recent Development
Table 73. WuXi AppTech Company Detail
Table 74. WuXi AppTech Business Overview
Table 75. WuXi AppTech Pharmaceutical CMO and CDMO Product
Table 76. WuXi AppTech Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 77. WuXi AppTech Recent Development
Table 78. WuXi Biologics Company Detail
Table 79. WuXi Biologics Business Overview
Table 80. WuXi Biologics Pharmaceutical CMO and CDMO Product
Table 81. WuXi Biologics Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 82. WuXi Biologics Recent Development
Table 83. Siegfried Company Detail
Table 84. Siegfried Business Overview
Table 85. Siegfried Pharmaceutical CMO and CDMO Product
Table 86. Siegfried Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 87. Siegfried Recent Development
Table 88. FUJIFILM Diosynth Biotechnologies Company Detail
Table 89. FUJIFILM Diosynth Biotechnologies Business Overview
Table 90. FUJIFILM Diosynth Biotechnologies Pharmaceutical CMO and CDMO Product
Table 91. FUJIFILM Diosynth Biotechnologies Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 92. FUJIFILM Diosynth Biotechnologies Recent Development
Table 93. Asymchem Company Detail
Table 94. Asymchem Business Overview
Table 95. Asymchem Pharmaceutical CMO and CDMO Product
Table 96. Asymchem Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 97. Asymchem Recent Development
Table 98. Pfizer CentreOne Company Detail
Table 99. Pfizer CentreOne Business Overview
Table 100. Pfizer CentreOne Pharmaceutical CMO and CDMO Product
Table 101. Pfizer CentreOne Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 102. Pfizer CentreOne Recent Development
Table 103. Delpharm Company Detail
Table 104. Delpharm Business Overview
Table 105. Delpharm Pharmaceutical CMO and CDMO Product
Table 106. Delpharm Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 107. Delpharm Recent Development
Table 108. Recipharm Company Detail
Table 109. Recipharm Business Overview
Table 110. Recipharm Pharmaceutical CMO and CDMO Product
Table 111. Recipharm Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 112. Recipharm Recent Development
Table 113. AGC Pharma Chemicals Company Detail
Table 114. AGC Pharma Chemicals Business Overview
Table 115. AGC Pharma Chemicals Pharmaceutical CMO and CDMO Product
Table 116. AGC Pharma Chemicals Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 117. AGC Pharma Chemicals Recent Development
Table 118. Boehringer Ingelheim Company Detail
Table 119. Boehringer Ingelheim Business Overview
Table 120. Boehringer Ingelheim Pharmaceutical CMO and CDMO Product
Table 121. Boehringer Ingelheim Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 122. Boehringer Ingelheim Recent Development
Table 123. Vetter Company Detail
Table 124. Vetter Business Overview
Table 125. Vetter Pharmaceutical CMO and CDMO Product
Table 126. Vetter Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 127. Vetter Recent Development
Table 128. Curia Company Detail
Table 129. Curia Business Overview
Table 130. Curia Pharmaceutical CMO and CDMO Product
Table 131. Curia Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 132. Curia Recent Development
Table 133. Aenova Company Detail
Table 134. Aenova Business Overview
Table 135. Aenova Pharmaceutical CMO and CDMO Product
Table 136. Aenova Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 137. Aenova Recent Development
Table 138. Porton Company Detail
Table 139. Porton Business Overview
Table 140. Porton Pharmaceutical CMO and CDMO Product
Table 141. Porton Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 142. Porton Recent Development
Table 143. Piramal Company Detail
Table 144. Piramal Business Overview
Table 145. Piramal Pharmaceutical CMO and CDMO Product
Table 146. Piramal Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 147. Piramal Recent Development
Table 148. Strides Pharma Company Detail
Table 149. Strides Pharma Business Overview
Table 150. Strides Pharma Pharmaceutical CMO and CDMO Product
Table 151. Strides Pharma Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 152. Strides Pharma Recent Development
Table 153. NextPharma Company Detail
Table 154. NextPharma Business Overview
Table 155. NextPharma Pharmaceutical CMO and CDMO Product
Table 156. NextPharma Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 157. NextPharma Recent Development
Table 158. Famar Company Detail
Table 159. Famar Business Overview
Table 160. Famar Pharmaceutical CMO and CDMO Product
Table 161. Famar Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 162. Famar Recent Development
Table 163. Jubilant Company Detail
Table 164. Jubilant Business Overview
Table 165. Jubilant Pharmaceutical CMO and CDMO Product
Table 166. Jubilant Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 167. Jubilant Recent Development
Table 168. Alcami Company Detail
Table 169. Alcami Business Overview
Table 170. Alcami Pharmaceutical CMO and CDMO Product
Table 171. Alcami Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 172. Alcami Recent Development
Table 173. Euroapi Company Detail
Table 174. Euroapi Business Overview
Table 175. Euroapi Pharmaceutical CMO and CDMO Product
Table 176. Euroapi Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 177. Euroapi Recent Development
Table 178. Eurofins Company Detail
Table 179. Eurofins Business Overview
Table 180. Eurofins Pharmaceutical CMO and CDMO Product
Table 181. Eurofins Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 182. Eurofins Recent Development
Table 183. Avid Bioservices Company Detail
Table 184. Avid Bioservices Business Overview
Table 185. Avid Bioservices Pharmaceutical CMO and CDMO Product
Table 186. Avid Bioservices Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 187. Avid Bioservices Recent Development
Table 188. BioVectra Company Detail
Table 189. BioVectra Business Overview
Table 190. BioVectra Pharmaceutical CMO and CDMO Product
Table 191. BioVectra Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 192. BioVectra Recent Development
Table 193. CPL Company Detail
Table 194. CPL Business Overview
Table 195. CPL Pharmaceutical CMO and CDMO Product
Table 196. CPL Revenue in Pharmaceutical CMO and CDMO Business (2018-2023) & (US$ Million)
Table 197. CPL Recent Development
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmaceutical CMO and CDMO Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Pharmaceutical CMO and CDMO Market Share by Type: 2022 VS 2029
Figure 3. API CMO and CDMO Features
Figure 4. FDF CMO and CDMO Features
Figure 5. Packaging CMO Features
Figure 6. Clinical CDMO Features
Figure 7. Global Pharmaceutical CMO and CDMO Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Pharmaceutical CMO and CDMO Market Share by Application: 2022 VS 2029
Figure 9. Pharmaceutical Company Case Studies
Figure 10. Biotechnology Company Case Studies
Figure 11. Other Case Studies
Figure 12. Pharmaceutical CMO and CDMO Report Years Considered
Figure 13. Global Pharmaceutical CMO and CDMO Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Pharmaceutical CMO and CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Pharmaceutical CMO and CDMO Market Share by Region: 2022 VS 2029
Figure 16. Global Pharmaceutical CMO and CDMO Market Share by Players in 2022
Figure 17. Global Top Pharmaceutical CMO and CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical CMO and CDMO as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Pharmaceutical CMO and CDMO Revenue in 2022
Figure 19. North America Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Pharmaceutical CMO and CDMO Market Share by Country (2018-2029)
Figure 21. United States Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Europe Pharmaceutical CMO and CDMO Market Share by Country (2018-2029)
Figure 25. Germany Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. France Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. U.K. Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Italy Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Russia Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Nordic Countries Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Asia-Pacific Pharmaceutical CMO and CDMO Market Share by Region (2018-2029)
Figure 33. China Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Japan Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. South Korea Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Southeast Asia Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. India Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Australia Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Latin America Pharmaceutical CMO and CDMO Market Share by Country (2018-2029)
Figure 41. Mexico Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Brazil Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Middle East & Africa Pharmaceutical CMO and CDMO Market Share by Country (2018-2029)
Figure 45. Turkey Pharmaceutical CMO and CDMO Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Saudi Arabia Pharmaceutical CMO and CDMO Market Size YoY

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs